BIS(tributyltin) oxide toxicology

Drug Metabolism Reviews

Volumn 29, Issue 4, 1997, Pages 1189-1280

  Benya, Theodore J ^a  

^a Xenobiotic Evaluation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(TRIBUTYLTIN) OXIDE; FUNGICIDE; MESSENGER RNA; PAINT; SEROTONIN;

ACUTE TOXICITY; BIOACCUMULATION; CARCINOGENICITY; CARDIOTOXICITY; CHRONIC TOXICITY; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; EYE TOXICITY; HUMAN; IMMUNE DEFICIENCY; LIVER TOXICITY; LUNG TOXICITY; MUTAGENICITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; REPRODUCTIVE TOXICITY; SKIN TOXICITY; SYMPTOM;

EID: 0031418180     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539709002247     Document Type: Conference Paper

References (271)

1. L. Knobeloch, in Morbidity and Mortality Weekly Report, Vol. 40, U.S. Department of Health and Human Services, 1991, pp. 280-281.
2. A. H. Penninks, N. J. Snoeij, R. H. H. Pieters, and W. Seinen, in Immunotoxicology of Metals and Immunotoxicology (A. D. Day an et al., eds.), Plenum Press, New York, 1990, pp. 191-207.
3. I. Ishaaya, J. L. Engel, and J. E. Casida, Pestic. Biochem. Physiol., 6, 270 (1976).
4. J. G. Vos, A. de Klerk, E. I. Krajnc, W. Kruizinga, B. Van Ommen, and J. Rozing, Toxicol. Appl. Pharmacol., 75, 387 (1984).
5. E. I. Krajnc, P. W. Wester, J. G. Loeber, F. X. R. Van Leeuwen, J. G. Vos, H. A. M. G. Vaessen, and C. A. Van Der Heijden, Toxicol. Appl. Pharmacol., 75, 363 (1984).
6. W. Seinen and A. H. Penninks, N. Y. Acad. Sci., 320, 499 (1979).
7. N. J. Snoeij, A. A. J. Van Iersel, A. Penninks, and W. Seinen, W., Toxicol. Appl. Pharmacol., 81, 274 (1985).
8. N. J. Snoeij, A. H. Penninks, and W. Seinen, Int. J. Immunopharmacol., 10, 891 (1988).
9. I. Penn, in Immunotoxicology and Immunopharmacology (J. H. Dean, M. I. Luster, and A. E. Munson, eds.), Raven Press, New York, 1985, pp. 69-82.
10. J. D. Sherman, et al., Toxicol. Ind. Health, 7, 197-205 (1991), in Patty's Industrial Hygiene and Toxicology, 4th ed. (G. D. Clayton and F. E. Clayton, eds.), 1994, p. 2496.
11. J. D. Sherman, et al., Toxicol. Ind. Health, 7, 197-205 (1991), in Patty's Industrial Hygiene and Toxicology, 4th ed. (G. D. Clayton and F. E. Clayton, eds.), 1994, p. 2496.
12. B. Brooks and J. Sullivan, in Hazardous Materials Toxicology: Clinical Principles of Environmental Health (J. Sullivan and G. Kreiger, eds.), Williams & Wilkins, Baltimore, MD, 1992, pp. 190-214.
13. W. Lyle, Br. J. Ind. Med., 15, 193 (1958).
14. G. J. M. Van der Klerk, in Organotin Compounds: New Chemistry and Applications (J. J. Zuckerman, ed.), Advances in Chemistry Series, Vol. 157, ACS, Washington, D.C., 1976, pp. 1-25.
15. W. T. Piver, Environ. Health Perspect., 4, 61 (1973).
16. G. J. M. Van Der Klerk and J. G. A. Lujijten, J. Appl. Chem., 4, 314 (1954), in [12, 16].
17. R. J. Zedler, Tin and Its Uses, 53, 1 (1961).
18. WHO, Tributyltin compounds. Environmental Health Criteria Vol. 116, World Health Organization, 1211 Geneva 27, Switzerland, pp 1-273; (17a), p. 36; (17b), p. 17; (17c), p. 16; (17d). p. 71; (17e), p. 72; (17f), p. 47; (17g), p. 52; (17h), p. 176; (17i), p. 155; (17j), p. 156; (17k), p. 178; (171), p. 179; (17m), p. 160; (17n). p. 187; (17o), p. 27; (17p). p. 166; (17q), p. 190; (17r), p. 189; (17s), p. 192; (17t), p. 185; (17u), p. 14; (17v), p. 38; (17w), p. 39; (17x), p. 41; (17y), p. 40; (1990).
19. J. Schrantz, Indust. Finishing, 66, 58 (1990).
20. R. W. Drisko and J. B. Crilly, J. Paint Technol., 46, 48 (1974).
21. T. P. White, Arch. Exp. Path. Pharmak, xii, 53 (1880-1881), in [21].
22. P. N. Magee, H. B. Stoner, and J. M. Barnes, J. Pathol. Bacteriol., 73, 107 (1957).
23. R. Truhaut, Y. Chauvel, J. P. Anger, N. Phu Lieh, J. Van Den Driessche, and L. R. Guesnier with the technical assistance of N. Morin (C.N.R.S.), Eur. J. Toxicol., 9, 31 (1976).
24. F. Jolyet and A. Cahours, C.R. Sci., 68, 1276 (1869), in [22].
25. J. R. Elsea and O. E. Paynter, A.M.A. Arch. Ind. Health, 18, 214 (1958).
26. Z. Pelikan and E. Cerny, Arch. Toxicol., 23, 283 (1968).
27. M. C. Middleton and I. Pratt, J. Invest. Dermatol., 68, 379 (1977), in [17i].
28. M. C. Middleton and I. Pratt, J. Invest. Dermatol., 71, 305 (1978), in [17j].
29. M. C. Middleton, J. Invest. Dermatol., 79, 163 [Abstract] (1982).
30. WHO, Tin and Organotin Compounds, Environmental Health Criteria Document, 15, World Health Organization, Geneva, (a) p. 24, (b) p. 91, (c), p. 77 (1980).
31. H. B. Stoner, J. M. Barnes, and J. I. Duff, Br. J. Pharmacol., 10, 16 (1955).
32. N. Funahashi, I. Iwasaki, and G. Ide, Acta Pathol. Jpn., 30, 955 (1980).
33. H. Schweinfurth, Tin and Its Uses, 143, 9 (1985).
34. O. R. Kimmer, Arztl-Forsch., 19, 934 (1969), in [14].
35. P. Poitou, B. Marignac, C. Certin, and D. Gradiski, Ann. Pharm. F., 36, 569 (1978).
36. I. M. Robinson, Food Cosmet. Toxicol., 7, 47 (1969).
37. H. Van Loveren, E. I. Krajnc, P. J. A. Rombout, F. A. Blommaert, and J. G. Vos, Toxicol. Appl. Pharmacol, 102, 21 (1990).
38. (a) J. M. Barnes and H. B. Stoner, Br. J. Ind. Med., 15, 15 (1958);
39. (b) in [12].
40. Z. Pelikan and E. Cerny, Berufs Dermatosen, 16, 340 (1968), in [39].
41. Z. Pelikan and E. Cerny, Berufs Dermatosen, 17, 305 (1969).
42. Z. Pelikan, Br. J. Ind. Med., 26, 165 (1969).
43. M. Yoshizuka, N. Haramaki, M. Yokoyama, K. Kara, A. Kawahara, Y. Umezu, H. Araki, N. Mori, and S. Fujimoto, Arch Toxicol., 65, 651 (1991).
44. M. Yoshizuka, K. Kara, N. Haramaki, M. Yokoyama, N. Mori, Y. Doi, A. Kawahara, and S. Fugimoto, Arch Toxicol., 66, 182 (1992).
45. M. Yoshizuka, K. Hara et al, Histol. Histophthol., 7, 445 [Abstract] (1992).
46. J. M. Bames and P. N. Magee, J. Pathol. Bacteriol., 75, 267 (1958).
47. I. J. Boyer, Toxicology, 55, 253 (1989).
48. Y. Mori, K. Iesato, et al, Nippon Jinzo Gakkai Shi, 23, 89 [Abstract Translation] (1981).
49. Y. Mori, K. lesato, et al, Jpn. J. Nephrol., 23, 89 [Abstract] (1981).
50. Y. Mori, K. lesato, S. Ueda, T., Mori, I. Iwasaki, K. Ohnishi, Y. Seino, Y. Wakashin, M. Wakashin, and K. Okuda, Clin. Nephrol., 21, 118 (1984).
51. P. A. Botham, Adverse Drug React., Acute Poisoning Rev. [United Kingdom], 9, 91 (1990).
52. H. Van Loveren, H-J. Schuurman, J. Kampinga, and J. G. Vos, Int. J. Immmopharmac., 13, 369 (1991).
53. W. Seinen, J. G. Vos, I. Van Spanje, M. Snoek, R. Brands, and H. Hooykaas, Toxicol. Appl. Pharmacol., 42, 197 (1977).
54. W. Seinen and M. I. Willems, Toxicol. Appl. Pharmacol., 35, 63 (1976), in [53].
55. W. Seinen, J. G. Vos, R. Brands, and H. Hooykaas, Immunopharmacology, 1, 34 (1979).
56. W Seinen, J. G. Vos, R. Van Krieken, A. H. Penninks, R. Brands, and H. Hooykaas, Toxicol. Appl. Pharmacol., 42, 213 (1977), in [53].
57. J. F. Bach, Nature, 222, 998 (1969), in [53].
58. N. Fabris and L. Piantanelli, Clin. Exp. Immunol., 28, 315 (1977).
59. In American Hospital Formulary Service [ASFS], Drug Information, American Society of Health-System Pharmacists, Inc., Bethesda, MD, 1992, (a) pp. 2252-2254, (b) pp. 577-582, (c) p. 1302, (d) p. 1237.
60. J. G. Vos, E. I. Krajnc, and P. W. Wester, in Immunotoxicology and Immunopharmacology (J. H. Dean and M. I. Luster, eds.), Raven Press, New York, 1985, pp. -327-340.
61. R. H. H. Pieters, J. Kampinga, M. Bol-Schoenmakers, B. W. Lam, A. H. Penninks, and W. Seinen, Thymus, 14, 79 (1989).
62. J. Nikolic-Zugic, Immunol. Today, 12, 65 (1991), in [87].
63. R. Scollay, P. Barlett, and K. Shortman, Immunol. Rev., 182, 79 (1984), in [87].
64. R. Scollay, A. Wilson, A. D'Amico, K. Kelly, M. Egerton, M. Pearse, L. Wu, and K. Shortman, Immunol. Rev., 104, 81 (1988), in [87].
65. N. J. Snoeij, Triorganotin Compounds in Immunotoxicology and Biochemistry. Ph.D. Thesis, University of Utrecht, The Netherlands, in [2].
66. R. J. Smialowicz, M. M. Riddle, R. R. Rogers, R. W. Luebke, and C. B. Copeland, Toxicology, 57, 97 (1989).
67. R. J. Smialowicz, M. M. Riddle, R. R. Rogers, R. W. Luebke, C. B. Copeland, and G. G. Ernst, Toxicology, 64, 169 (1990).
68. A. H. Penninks, R. H. H. Pieters, N. J. Snoeij, and W. Seinen, in Organotin-induced Thymus Atrophy, in Thymus Update, Vol. 4 (M. D. Kendall and M. A. Ritter, eds.), Harwood Academic Publishers, London, U.K. [Abstract], 1991, pp. 57-79.
69. D. J. Paterson and A. F. Williams, J. Exp. Med., 166, 1603 (1987), in [66].
70. R. H. H. Pieters, M. Bol, B. W. Lam, W. Seinen, and A. H. Penninks, Immunology, 76, 203 (1992).
71. R. H. H. Pieters, M. Bol., B. W. Lam, W. Seinen N. Bloksma, and A. H. Penninks, Immunology, 78, 616 (1993), in [87].
72. G. Tiefenthaler, T. Hanke, and T. Hunig, Int. Immunol., 4, 825 (1992), in [87].
73. J. Reimann, Scand. J. Immunol., 34, 679 (1991), in [87].
74. E. I. Krajnc, J. G. Vos, P. W. Wester, J. F. Loeber, and C. A. Van der Heijden, in Toxicology and Analytics of the Tributyltins, The Present Status, ORTEPA Workshop, Berlin, May 15-16 (1987), in [2].
75. P. W. Wester, E. I. Krajnc, and C. A. Van der Heijden, in Toxicology and Analytics of the Tributyltins - The Present Status, ORTEPA Workshop, Berlin, May 15-16 (1987), in [2].
76. P. W. Wester, E. I. Krajnc, F. X. R. Van Leeuwen, J. G. Loeber, C. A. Van Der Heijden, H. A. M. G. Vaessen, and P. W. Helleman, Food Chem. Toxicol., 28, 179 (1990).
77. J. G. Vos, A. De Klerk, E. I. Krajnc, H. Van Loveren, and J. Rozing, Toxicol. Appl. Pharmacol, 105, 144 (1990).
78. W. Seinen and M. I. Willems, Toxicol. Appl. Pharmacol., 35, 63 (1976), in [2].
79. K. Miller, M. P. Scott, and J. R. Foster, Clin. Immunol. Immunopathol, 30, 62 (1984), in [2].
80. E. C. Kimmel, R. H. Fish, and J. E. Casida,. J. Agric. Food Chem., 25, 1 (1977).
81. H. Iwai, O. Wada, and Y. Arawaka, J. Anal. Toxicol., 5, 300 (1981).
82. N. J. Snoeij, A. H. Penninks, and W. Seinen, Environ. Res., 44, 335 (1987).
83. T. Y. Aw, P. Nicotera, L. Manzo, and S. Orrenius, Arch. Biochem. Biophys., 283, 46 (1990).
84. M. Raffray and G. Cohen, Arch. Toxicol., 65, 135 (1991).
85. T. G. Cotter, S. V. Lennon, J. G. Glynn, and S. J. Martin, Anticancer Res., 10, 1153 (1990), in [82].
86. W. N. Aldridge and B. W. Street, Biochem. J., 91, 287 (1964).
87. M. Raffray and G. Cohen, Arch. Toxicol., 67, 231 (1993).
88. M. Raffray, D. McCarthy, R. T. Snowden, and G. M. Cohen, Toxicol. Appl. Pharmacol., 119, 122 (1993).
89. R. H. H. Pieters, M. Bol, and A. H. Penninks, Toxicology, 91, 189 (1994).
90. G. Bressa, R. H. Hinton, S. C. Price, M. Isbir, R. S. Ahmed, and P. Grasso, J. Appl. Toxicol., 11, 397 (1991).
91. F. Verdier, M. Virat, H. Schweinfurth, and J. Descotes, J. Toxicol. Environ. Health, 32, 307 (1991).
92. E. J. De Waal, H-J. Schuurman, L. H. P. M. Rademakers, H. Van Loveren, and J. G. Vos, Arch. Toxicol., 67, 86 (1993).
93. C. Meredith and M. P. Scott, Toxicol. In Vitro, 8, 751 (1994).
94. C. P. Stringer, R. Hicks, and P. A. Botham, Contact Derm., 24, 210 (1991).
95. C. L. Goh, Contact Derm., 12, 161 (1985).
96. P. G. Lewis and E. A. Emmett, Contact Derm., 77, 129 (1987).
97. L. Molin and J. E. Wahlberg, Berufs-Dermatosen, 23, 138 (1975).
98. C. D. Calnan, in Occupational and Industrial Dermatology (H. I. Maibach, ed.), Chicago, Yearbook, 1987, pp. 28-31.
99. C. T. Grace, S. K. Ng, and L. H. Lee, Contact. Derm., 25, 250 (1991).
100. D. Stanworth, in Immunotoxicology (G. G. Gibson, R. Hubbard, and D. V. Parke, eds.), Academic Press, New York, 1983, pp. 71-86.
101. W. Ptak, W., M. Rewicka, J. Strzyzewska, and M. Kolla, Clin. Exp. Immunol., 52, 54 (1983).
102. G. Thompson, Nature (London), 275, 748 (1967), in [56].
103. W. Pierpaoli, N. Fabris, and E. Sorkin, in Cellular Interaction in the Immune Response, 2nd Int. Convoc. Immunol., Buffalo New York, 1970, in [56].
104. P. M. Lundin and L. Angervall, Pathol. Eur., 5, 273 (1970), in [56].
105. J. Barth and M. Rytter, Arbeitshygien. Inform. Bauwesen, 9, 78 (1973), in [95].
106. V. Ziegler, E. Suss, and H. Standau, Arbeitshygien. Inform. Bauwesen, 9, 74 (1973), in [95].
107. M. Gammeltoft, Contact Derm., 4, 238 (1978).
108. H. Terada, Env. Health Perspect., 87, 213 [Abstract] (1990).
109. A. T. Gardlund, T. Archer, K. Danielsson, B. Danielsson, A. Fredriksson, N-G Lindqvist, H. Lindstrom, and J. Luthman, Neurotoxicol. Teratol., 13, 99 (1991).
110. K. E. Stine, L. W. Reiter, and J. J. LeMasters, Toxiocol. Appl. Pharmacol., 94, 394 (1988), in [107].
111. W. N. Aldridge and J. E. Cremer, Biochem. J., 61, 406 (1955), in [110].
112. W. N. Aldridge, Biochem. J., 69, 367 (1958).
113. J. M. Barnes and H. B. Stoner, Pharmacol. Rev., 11, 211 (1959).
114. M. Stockdale, A. P., Dawson, and M. J. Selwyn, Eur. J. Biochem., 15, 342 (1970).
115. K. Cain, R. L. Hyams, and D. E. Griffiths, FEBS Lett., 82, 23 (1977).
116. W. N. Aldridge, B. W. Street, and D. N. Skilleter, Biochem. J., 168, 353 (1977).
117. N. J. Snoeij, P. Punt, A. H. Penninks, and W. Seinen, Biochim. Biophys. Acta, 852, 234 (1986).
118. M. Yoshizuka, K. Hara, N. Nagata, Y. Doi, M. Yokoyama, T. Sagara, and S. Fujimoto, Tissue Cell, 24, 725 (1992).
119. T. Alajouanine, L. Derobert, and S. Thieffry, Rev. Neurol., 98, 85-96 (1958), in (a) [122], (b) [111] and in [29b].
120. (a) In Detoxification Mechanisms (R. T. Williams, ed.), J. Wiley & Sons Inc., New York, 1947, p. 136;
121. (b) W. D. Homer, Arch. Ophthalmol., 27, 1097 (1942), in A. M. Potts and L. M. Gonasun, Toxiocology, The Basic Science of Poisons (L. J. Casarett and J. Doull, eds.), Macmillan, New York, 1975, p. 286.
122. (b) W. D. Homer, Arch. Ophthalmol., 27, 1097 (1942), in A. M. Potts and L. M. Gonasun, Toxiocology, The Basic Science of Poisons (L. J. Casarett and J. Doull, eds.), Macmillan, New York, 1975, p. 286.
123. R. E. Allan, in Patty's Industrial Hygiene and Toxicology, Vol. II, Part B, Wiley, New York, 1994, pp. 1610-1611.
124. M. J. Kland, in Teratogens, Chemicals Which Cause Birth Defects (Vera Kolb Meyers, ed.), Elsevier, New York, 1988, p. 235.
125. S. J. Cooper, TIPS, FEB, 10, 56 (1989).
126. K. E. Moore and T. M. Brody, J. Pharmacol. Exp. Ther., 132, 6 (1961).
127. M. A. Wilson and M. E. Molliver, GL1A, 11, 18 (1994).
128. M. D. Ferrari, Neurology, 39, 1239 [Abstract] (1989).
129. N. N. Belyaeva, T. A. Bystrova, V. I. Arkhangel'skii, N. M. Losev, E. A. Demurov, G. A. Drozdova, V. V. Padalka, and V. A. Panteleimonov, Gig. Sanit., 9, 96 (1974), in [192].
130. S. V. Doctor and D. A. Fox, J. Toxicol. Environ. Health, 10, 43 (1982).
131. J. P. O'Callaghan and D. B. Miller, J. Pharmacol. Exp. Ther., 246, 394 (1988).
132. J. P. Anger, Contribution a l'etude analytique, toxicologique et biochimique de l'oxyde de tributyletain, These, Doctorat, Pharmacie, Etat, Paris, (1975), in [22].
133. G. De Saqui-Sannes, Recherches experimentales sur la toxicite de quelques derives organostanniques, These, Doctorat, Pharmacie, Universite, Toulouse (1957), in [22].
134. T. Itami, M. Ema, H. Amano, T. Murai, and H. Kawasaki, Drug Chem. Toxicol., 13, 283 (1990), in [131].
135. M. Ema, T. Itami, and H. Kawasaki, Toxicol. Lett., 58, 347 (1991).
136. T. Noda, S. Morita, T. Yamano, M. Shimizu, T. Nakamura, M. Saitoh, and A. Yamada, Toxicol. Lett., 55, 109 (1991).
137. T. Kato and S. Kitagawa, Toxicol. Appl. Pharmacol., 27, 20 (1974), in [132].
138. C. A. Kimmel and J. G. Wilson, Teratology, 8, 309 (1973), in [132].
139. M. Yasuda and H. Maeda, Congen. Anom., 13, 25 (1973), in [132].
140. H. Iwai, S. Komatsu, S. Manabe, H. Matsui, T. Ono, and O. Wada, J. Toxicol. Sci., 7, 272 [Abstract] (1982).
141. A. Davis, R. Barale, G. Brun, R. Forster, T. Gunther, H. Hautefeuille, C. A. van der Heijden, A. G. A. C. Knaap, R. Krowke, T. Kuroki, N. Loprieno, C. Malaveille, H. J. Merker, M. Monaco, P. Mosesso, D. Neubert, H. Norppa, M. Sorsa, E. Vogel, C. E. Voogd, M. Umeda, and H. Bartsch, Mutat. Res., 188, 65 (1987).
142. M. D. Nemec, A teratology study in rabbits with TBTO: Final Report, Wil Research Laboratories Inc., 210 pp. (Report No. WILB0002) in [17t].
143. K. M. Crofton, K. F. Dean, V. M. Boncek, M. B. Rosen, L. P. Shees, N. Chernoff, and L. W. Reiter, Toxicol. Appl. Pharmacol., 97, 113 (1989).
144. S. Baroncelli, D. Karrer, and P. G. Turillazzi, Toxicol. Lett., 50, 257 (1990).
145. S. Baroncelli, D. Karrer, and P. G. Turillazzi, Int. J. Toxicol. Environ. Health, 46, 355 (1995).
146. N. A. Brown, Arch Toxicol. 11, (Suppl.) 105 (1987), in [143].
147. J. Yonemoto, H. Shiraishi, and Y. Soma, Toxicol. Lett., 66, 183 (1993).
148. J. Yonemoto and A. Kawagoe, Environ. Sci., 1, 127 (1992), in [143].
149. R. Krowke, U. Bluth, and D. Neubert, Arch. Toxicol., 58, 125 (1986).
150. D. Neubert, G. Blankenburg, I. Chahoud, G. Franz, R. Herken, M. Kastner, S. Klug, J. Kroger, R. Krowke, C. Lewandowski, H-J Merker, T. Schulz, and R. Stahlmann, Environ. Health Perspect., 70, 89 (1986).
151. H-J Barrach and D. Neubert, Teratology, 33, 63C [Abstract] (1986).
152. I. Iwasaki, N. Funahashi, S. Toizumi, and G. Ide, J. Toxicol. Sci., 7(2), 99 (213), (1976), in [48].
153. I. Iwasaki, N. Funahashi, and G. Ide, J. Toxicol. Sci., 2, 106 (1977), in [48].
154. N. Funahashi, I. Iwasaki, S. Toizumi, and G. Ide, J. Toxicol. Sci., 1(2), 99 (213) (1976), in [48].
155. V. T. Mazaev and T. G. Slepnina, Gig. Sanit., 8, 10 (1973), in [29c].
156. N. N. Belyaeva, T. A. Bystrova, Yu. A. Revazova, and V. I. Arkhangel'skii, Gig. Sanit. 5, 10 (1986), in [153].
157. D. R. Dixon and H. Presser, Aquat. Toxicol. (Amst.), 8, 185 (1986).
158. A. O. Li, A. R. Dahl, and J. O. Hill, Toxicol. Appl. Pharmacol., 64, 482 (1982), in [45].
159. J. A. J. Thompson et al, in The Aquatic Environment. National Research Council of Canada (1985), in [156].
160. D. R. Dixon and I. McFadzen, Mutagenesis, 2, 312 (1987).
161. H. Yamada and Yu. F. Sasaki, Mutat. Res., 301, 195 (1993).
162. A. Kanetoshi, Eisei Kagaku, 29, 303 (1983), in [153].
163. J. Hooson and P. Grasso, Toxicology. 7, 1 (1977), in [153].
164. Midwest Research Institute, Assessment of the need for limitations on organotins. Draft Final Report, U.S. EPA Contract No. 68-01-4313. Office of Toxic Substances, Washington, DC (1979), in [153].
165. M. C. Middleton, J. Invest. Dermatol., 79, 163 (1982), in [153].
166. J. G. Vos and H. Van Loveren, Toxicol. In Vitro, 8, 951 (1994).
167. K. H. Byington, R. Y. Yeh, and L. R. Forte, Toxicol. Appl. Pharmacol., 27, 230 (1974).
168. M. Porvaznik, B. H. Gray, D. Mattie, A. G. Jackson, and R. E. Omlor, Lab. Invest., 54, 254 (1986).
169. T. L. Johnson and C. O. Knowles, Toxicology, 29, 39 (1983).
170. I. F. Gaunt et al, Food Cosmet. Toxicol., 6, 599 [Abstract] (1968).
171. K. Yumoto, J. Tokyo Med. Coll., 33, 157 (1976), in [192].
172. D. W. Rosenberg, G. S. Drummond, H. C. Cornish, and A. Kappas, Biochem J., 190, 465 (1980).
173. D. W. Rosenberg, G. S. Drummond, and A. Kappas, Mol. Pharmacol., 21, 150 (1981).
174. D. W. Rosenberg and G. S. Drummond, Biochem. Pharmacol., 32, 3823 (1983).
175. D. W. Rosenberg, K. E. Anderson, and A. Kappas, Biochem. Biophys. Res. Commun., 119, 1022 (1984).
176. D. W. Rosenberg and A. Kappas, Biochem. Pharmacol., 38, 1155 (1989).
177. Y. Arakawa and O. Wada, Biochem. Biophys Res Commun., 123, 543 (1984), in [174].
178. J. S. Morrow and R. A. Anderson, Lab. Invest., 54, 237 (1986).
179. J. E. Casida and E. C. Kimmel, Acta Chem. Scand., 25, 1497 [Abstract] (1971).
180. R. H. Fish, E. C. Kimmel, and J. E. Casida, J. Organometal. Chem., 93, C1 (1975) in [78].
181. R. H. Fish, E. C. Kimmel, and J. E. Casida, in Organotin Compounds: New Chemistry and Applications (J. J. Zuckerman, ed.), Washington, DC: American Chemical Society, Washington, DC, 1976 [Abstract], pp. 197-203.
182. W. H. Evans, N. F. Cardarelli, et al, J. Toxicol. Environ. Health, 5, 871 [Abstract] (1979).
183. M. Kumpel, G. Kuhne, et al, in Toxicology and Analytics of the Tributyltins: The Present Status. Proceedings of an ORTEPA Workshop (Vlissingen-Oost: ORTEP-Association), 1986, pp. 122-142, in [He].
184. A. H. Penninks, Food Addit. Contain., 10, 351 (1993).
185. H. Iwai, M. Manabe, et al, J. Toxicol. Sci., 5, 257 1980, in [17d].
186. R. H. Fish, E. C. Kimmel, and J. E. Casida, J. Organomet. Chem., 118, 41 (1976), in [78].
187. R. H. Fish, E. C. Kimmel, and J. E. Casida, Adv. Chem. Ser., (1976), in [78].
188. R. S. Tobias, in Organotin Workshop Report, (M. Gopod, ed.), University of New Orleans, New Orleans, LA, February, 17-19, 1978, pp. 21-27, in [185].
189. N. F. Cardarelli and W. Evans, in Controlled Release of Bioactive Materials (R. Baker, ed.), Academic Press, New York, 1980, pp. 357-385.
190. W. N. Aldridge and B. W. Street, Medical Research Council Laboratories, Carshalton, Surrey, England, 1976, in [78].
191. E. C. Kimmel, R. H. Fish, and J. E. Casida, unpublished results (1976), in [78].
192. W. N. Aldridge, J. E. Casida, R. H. Fish, E. C. Kimmel, and B. W. Street, Biochem. Pharmacol., 26, 1997 (1977).
193. S. Uhl, in Population exposure to the environmental chemical pentachlorophenol (PCP) and bis(tri-n-butyltin) oxide (TBTO), ETH Thesis No. 8014, University of Gottingen (Zurich: Maus Offsetdruck Konstanz), 1986, pp. 1-145, in [17e].
194. R. B. Laughlin, Jr., W. French, and H. E. Guard, Environ. Sci. Technol., 20, 884 [Abstract] (1986).
195. J. Duncan, Pharmacol. Ther., 10, 407 (1980).
196. D. Kloetzer and U. Thust, Chem. Technol., 28, 614 (1976), in [193].
197. R. Truhaut, J. P. Anger, F. Anger, A. Brault, P. Brunet, Y. Cano, M. Louvet, J. C. Saccavini, and J. Van Den Driessche and the technical assistance of C. Janson and Y. Sublet, Toxicol. Eur. Res., 3, 35 (1981).
198. A. G. Davies and P. J. Smith, in Advances in Inorganic Chemistry and Radiochemistry, Academic Press Inc, 1980, p. 46, in [87].
199. A. H. Penninks and W. Seinen, in Advances in Immunopharmacology (J. W. Hadden, L. Chedid and P. Dukor, eds.) Vol. 2, Pergamon Press, Oxford and London, 1983 [Abstract], p. 41.
200. A. W. Sheldon, J. Paint Technol., 47, 54 (1975).
201. M. S. Rose, Biochem. J., 111, 129 (1969) in [14]..
202. M. S, Rose and W. N Aldridge, Biochem. J., 106, 821 (1968), in [112].
203. W. N. Aldridge, in Organotin Compounds: New Chemistry and Applications (J. J. Zuckermann, ed.), American Chemical Society, Washington, D.C., Adv. Chem. Ser., 157, 1976, pp. 186-196.
204. M. S. Rose and E. A. Lock, Biochem. J., 120, 151 (1970), in [201].
205. A. P. Singh and P. D. Bragg, Can. J. Biochem., 57, 1384 (1979).
206. B. G. Farrow and A. P. Dawson, Eur. J. Biochem., 86, 85 (1978), in [201].
207. A. A. Karande, S. S. Ganti, and M. Udhayakumar, Indian J. Marine Sci., 22, 153 (1993).
208. J. W. Short and F. P. Thrower, Mar. Pollut. Bull., 17, 542 (1986).
209. K. Landa, J. Fejfusova, et al, Pracovni Lekarstvi., 25, 91 [Abstract] (1973).
210. P. M. Wax and L. Dockstader, Clin. Toxicol., 33, 239 (1995).
211. P. A. Baaijens, in Toxicology and analytics of the tributyltins: the present status, Proceedings of an ORTEPA workshop, Berlin, May 15-16, Vlissinger-Oost, The Netherlands, ORTEP-Associations, May 15-16, 1986, pp. 191-208, in [17q].
212. th Edition (A. Goodman Gilman, L. S. Goodman, T. W. Rall, and F. Murad, eds.), Macmillan, 1985, pp. 628-638.
213. D. Shelton, B. Urch, and S. M. Tario, J. Allergy Clin. Immunol., 90, 274 (1992).
214. WHO/FAO, Data sheet on pesticides No. 65: Bis (tributyltin)oxide, Geneva, World Health Organization, in [17r].
215. K. Akatsuka, J. Miyazawa, I. Igarashi, M. Morishita, A. Handa, N. Kawame, I. Iwamoto, F. Morito, K. Murayama, S. Nakano, H. Yanagibashi, T. Nagasaki, Y. Kotani, W. Matsutani, I. Fukuda, and T. Iyo, J. Tokyo Med. Coll., 17, 1393 (1959), in [17s].
216. G. B. Buckton, Proc. Roy. Soc., 9, 309 (1858), in [111].
217. A. W. Brown, W. N. Aldridge, B. W. Street, and R. D. Verschoyle, Am. J. Pathol, 97, 59 (1979).
218. P. Smith, M. Borchers, J. Kues and L. Hasse, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 87-90.
219. Malcolm H. T. Roberts, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 69-76.
220. J. W. Lance, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryplamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 19-28.
221. L. Edvinsson, I. Jansen and J. Olesen, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 129-136.
222. J. R. Fozard, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 200-219.
223. N. H. Raskin, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 311-316.
224. D. E. Clarke, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press. New York, 1992, pp. 118-128.
225. L. O. Wilkinson and C. T. Dourish, in Serotonin Receptor Subtypes: Basis and Clinical Aspects (S. J. Peroutka, ed.), Wiley-Liss, New York, 1991, pp. 147-210.
226. D. I. Wallis and H. Crick, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 77-86.
227. T. J. Verbeuren, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P. R. Saxena, eds.), Raven Press, New York, 1992, pp. 29-39.
228. M. D. Ferrar and G. M. J. van Kempen, in Frontiers in Headache Research, Volume 2, 5-Hydroxy Tryptamine Mechanisms in Primary Headaches (V. Olesen and P, R. Saxena, eds.), Raven Press, New York, 1992, pp. 189-199.
229. K. N. Huang and D. Julius, in Serotonin Receptor Subtypes: Basis and Clinical Aspects, (S. J. Peroutka, ed.), Wiley-Liss, New York, 1991, pp. 1-17.
230. In Gifford's Textbook of Ophthalmology (F. H. Adler, ed.), WB Saunders, Philadelphia, 1984, p. 221.
231. In Ophthalmic Pathology, An Atlas and Textbook, 2nd ed. (M. J. Hogan and L. E. Zimmerman, eds.), WB Saunders, Philadelphia, 1962, p. 797, in Wester et al. (1987) [228].
232. P. W. Wester and J. H. Canton, Aquat. Toxicol., 10, 143 (1987).
233. In Toxicology of the Eye, 2nd ed. (W. M. Grant, ed.), Charles C. Thomas, Springfield, IL, 1974, p. 26.
234. B. O. Brooks, F. D. Aldrich, G. M. Utter, J. A. DeBroy, and R. D. Schimke, Ann. N.Y. Acad. Sci., 641, 199 (1992).
235. R. B. Rees, Jr., in Current Medical Diagnosis and Treatment (M. A. Krupp and M. J. Chatton, eds.), Lange Medical Publications, Los Altos, CA, 1979, p. 76.
236. E. S. Bush and S. E. Mayer, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, eds), McGraw-Hill, New York, 1996, pp. 249-263.
237. P. Trouillas, in Serotonin, the Cerebellum and Ataxia (P. Trouillas and K. Fuxe, eds), Raven Press, New York, 1993, pp. 323-334.
238. In Best and Taylor's Physiological Basis of Medical Practice, 12th ed. (J. B. West, ed.), Williams & Wilkins, Baltimore, MD, 1990, pp. 999-1011.
239. S. H. Snyder, in Basic Neurochemistry, 2nd ed. (G. J. Siegel, R. W. Albers, R. Katzman, and B. W. Agranoff, eds.), Little, Brown, Boston, 1976, pp- 212-215.
240. T. W. Burns, in Pathologic Physiology Mechanisms of Disease (W. A. Sodeman, Jr., and W. A. Sodeman, eds.), WB Saunders, Philadelphia, 1974, pp. 865-914.
241. In American Hospital Formulary Service [ASFS], Drug Information, American Society of Health-System Pharmacists, Inc., Bethesda, MD, 1996, pp. 1319-1322.
242. In Andrews' Diseases of the Skin, Clinical Dermatology (Anthony N. Domonkos, ed.), WB Saunders, Philadelphia, 1971, p. 125.
243. R. J. Dearman and I. Kimber, Toxicol. In Vitro, 5, 519 (1991).
244. In Robbins Pathologic Basis of Disease, 5th ed. (R. S. Cotran, V. Kumar, and S. L. Robbins, eds.), WB Saunders, Philadelphia, 1994, pp. 583-627.
245. In Clinical Laboratory Methods, 8th ed. (J. D. Bauer, P. G. Ackermann, and G. Toro, eds.), CV Mosby, St. Louis, MO, 1974, p. 154.
246. W. B. Campbell and P. V. Halushka, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, eds.), McGraw-Hill, New York, 1996, pp. 601-616.
247. J. H. Karam, in: Current Medical Diagnosis and Treatment (M. A. Krupp and M. J. Chatton, eds.), Lange Medical Publications, Los Altos, CA, 1979, p. 763.
248. In Robbing Pathologic Basis of Disease, 5th ed. (R. S. Cotran, V. Kumar, and S, L. Robbins, eds.), WB Saunders, Philadelphia, 1994, pp. 1113-1171.
249. S. N. Davis and D. K. Granner, in Goodman and Gilman's The Pharmacological Basis of'Therapeutics, 9th ed. (J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, eds.), McGraw-Hill, New York, 1996, pp. 1506.
250. J. Climax et al, Irish J. Med. Sci., 153, 29 [Abstract] (1984).
251. N. R. Rose, in Principles of Immunology (N. R. Rose, F. Milgram, and C. J. Vanoss, eds.), Macmillan, New York, 1973, pp. 441-442.
252. In Basic Pathology, 2nd ed. (S. L. Robbins and M. Angell, eds.), WB Saunders, Philadelphia, 1976, p. 598.
253. T. W. Burns and H. E. Carlson, in Sodeman's Pathologic Physiology Mechanisms of Disease, 7th ed. (W. A. Sodeman and T. M. Sodeman, eds.), WB Saunders, Philadelphia, 1985, p. 1014.
254. In Basic Pathology, 2nd ed. (S. L. Robbins and M. Angell, eds.), WB Saunders, Philadelphia, 1976, p. 174.
255. J. M. Robson and F. M. Sullivan, J. Endocrinol., 25, 553 (1963), in B. A. Becker, Toxiocology, The Basic Science of Poisons (L. J. Casarett and J. Doull, eds.), Macmillan, New York, 1975, pp. 325-326.
256. J. M. Robson and F. M. Sullivan, J. Endocrinol., 25, 553 (1963), in B. A. Becker, Toxiocology, The Basic Science of Poisons (L. J. Casarett and J. Doull, eds.), Macmillan, New York, 1975, pp. 325-326.
257. In Metabolic and Endocrine Physiology, 3rd ed. (J. Tepperman, ed.), Year Book Medical Publishers, Chicago, 1973, p. 114.
258. J. A. Benjamins and G. M. McKhann, in Basic Neurochemistry, 2nd ed. (G. J. Siegel, R. W. Albers, R. Katzman, and B. W. Agranoff, eds.), Little, Brown, Boston, 1976, pp. 365-387.
259. In Differential Diagnosis, The Interpretation of Clinical Evidence, 2nd ed. (A. M. Harvey and J. Bordley, eds.), WB Saunders, Philadelphia, 1972, p. 624.
260. B. A. Becker, in Toxicology, The Basic Science of Poisons (L. J. Casarett, and J. Doull, eds.), Macmillan, New York, 1975, p. 325-326.
261. T. W. Burns and H. E. Carlson, in Sodeman's Pathologic Physiology Mechanisms of Disease, 7th ed. (W. A. Sodeman and T. M. Sodeman, eds.), WB Saunders, Philadelphia, 1985, p. 1000.
262. A. P. Kulkarni and E. Hodgson, in Introduction to Biochemical Toxicology (E. Hodgson and F. E. Guthrie, eds.), Eisevier, New York, 1980, p. 137.
263. In Textbook of Medical Physiology, 9th ed. (A. C. Guyton and J. E. Hall, eds.), WB Saunders, Philadelphia, 1996, p. 948-949.
264. J. A. Benjamins and G. M. McKhann, in Basic Neurochemistry, 2nd ed. (G. J. Siegel, R W. Albers, R. Katzman, and B. W. Agranoff, eds.), Little, Brown, Boston, 1976, p. 373.
265. In Toxicological Profile for Tin and Compounds, Agency for Toxic Substances and Disease Registry, Centers for Disease Control, U.S. Public Health Service, 1992.
266. In Textbook of Medical Physiology, 9th ed. (A. C. Guyton and J. E. Hall, eds.), WB Saunders, Philadelphia, 1994, p. 933.
267. S. L. Traub, in Basic Skills in Interpreting Laboratory Data, 2nd ed. (S. Traub, ed.), American Society of Health-System Pharmacists, Bethesda, MD, 1996, p. 248.
268. D. Henschler, in Occupational Toxicants: Critical Data Evaluation for MAK Values and Classification of Carcinogens, Vol. 1 (D. Henschler, ed.), VCH Verlagsgesellschaft mbH, Weinhbeim, 1991, pp. 315-333.
269. Federal Register, 1989, 29 CFR 1910.1000, (1989), in [1].
270. In Deutsche Forschungsgemeinschaft List of MAK and BAT Values, Report No. 32, VCH, Basel, Switzerland, 1996, p. 89.
271. NIOSH Pocket Guide to Chemical Hazards, Centers for Disease Control and Prevention, DHHS (NIOSH) Publication No. 94-116, U.S. Government Printing Office, Washington, DC, 1994.